Marie-Christine Chartier-Harlin
Overview
Explore the profile of Marie-Christine Chartier-Harlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
2757
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Landoulsi Z, Ashok Kumar Sreelatha A, Schulte C, Bobbili D, Montanucci L, Leu C, et al.
medRxiv
. 2024 Sep;
PMID: 39228715
Objective: Our study investigates the impact of copy number variations (CNVs) on Parkinson's disease (PD) pathogenesis using genome-wide data, aiming to uncover novel genetic mechanisms and improve the understanding of...
2.
Domenighetti C, Sugier P, Ashok Kumar Sreelatha A, Schulte C, Grover S, Portugal B, et al.
Neurology
. 2024 Jul;
103(3):e209620.
PMID: 38986057
Background And Objectives: The role of body mass index (BMI) in Parkinson disease (PD) is unclear. Based on the Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in PD...
3.
Naaldijk Y, Fernandez B, Fasiczka R, Fdez E, Leghay C, Croitoru I, et al.
NPJ Parkinsons Dis
. 2024 Jan;
10(1):12.
PMID: 38191886
Parkinson´s disease (PD) is a common neurodegenerative movement disorder and leucine-rich repeat kinase 2 (LRRK2) is a promising therapeutic target for disease intervention. However, the ability to stratify patients who...
4.
Iannotta L, Emanuele M, Favetta G, Tombesi G, Vandewynckel L, Lara Ordonez A, et al.
Front Mol Neurosci
. 2024 Jan;
16:1269387.
PMID: 38169846
Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of inherited and sporadic Parkinson's disease (PD) and previous work suggests that dephosphorylation of LRRK2 at a cluster of...
5.
Filippini F, Nola S, Zahraoui A, Roger K, Esmaili M, Sun J, et al.
Cell Rep
. 2023 Mar;
42(3):112221.
PMID: 36905628
The neuropeptide VGF was recently proposed as a neurodegeneration biomarker. The Parkinson's disease-related protein leucine-rich repeat kinase 2 (LRRK2) regulates endolysosomal dynamics, a process that involves SNARE-mediated membrane fusion and...
6.
Sugier P, Lucotte E, Domenighetti C, Law M, Iles M, Brown K, et al.
Mov Disord
. 2023 Feb;
38(4):604-615.
PMID: 36788297
Background: Epidemiological studies that examined the association between Parkinson's disease (PD) and cancers led to inconsistent results, but they face a number of methodological difficulties. Objective: We used results from...
7.
Taymans J, Mutez E, Sibran W, Vandewynckel L, Deldycke C, Bleuse S, et al.
NPJ Parkinsons Dis
. 2023 Feb;
9(1):21.
PMID: 36750568
Expression or phosphorylation levels of leucine-rich repeat kinase 2 (LRRK2) and its Rab substrates have strong potential as disease or pharmacodynamic biomarkers. The main objective of this study is therefore...
8.
Sileo P, Simonin C, Melnyk P, Chartier-Harlin M, Cotelle P
Cells
. 2022 Nov;
11(22).
PMID: 36429058
The Hippo pathway consists of a cascade of kinases that controls the phosphorylation of the co-activators YAP/TAZ. When unphosphorylated, YAP and TAZ translocate into the nucleus, where they mainly bind...
9.
Grover S, Ashok Kumar Sreelatha A, Pihlstrom L, Domenighetti C, Schulte C, Sugier P, et al.
Neurology
. 2022 Aug;
99(7):e698-e710.
PMID: 35970579
Background And Objectives: Considerable heterogeneity exists in the literature concerning genetic determinants of the age at onset (AAO) of Parkinson disease (PD), which could be attributed to a lack of...
10.
Domenighetti C, Douillard V, Sugier P, Ashok Kumar Sreelatha A, Schulte C, Grover S, et al.
Mov Disord
. 2022 Jul;
37(9):1929-1937.
PMID: 35810454
Background: Two studies that examined the interaction between HLA-DRB1 and smoking in Parkinson's disease (PD) yielded findings in opposite directions. Objective: To perform a large-scale independent replication of the HLA-DRB1 ...